Skip to content
INO$2.00+1.23(+159.13%)INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...[6:01:00 PM ET]KVUE$19.35-0.21(-1.07%)Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600 effective prior to the opening of trading on...[5:51:00 PM ET]ACET$3.42-0.16(-4.47%)Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)[5:38:00 PM ET]BKOR$31.900.00(0.00%)Oak Ridge Financial Services, Inc. Announces Third Quarter and Nine Months Ended September 30, 2026 Results and Quarterly Cash Dividend of $0.16 Per Common Share[5:32:47 PM ET]BHAVU$10.170.00(0.00%)BHAV Acquisition Corp II Announces Closing of $100 Million Initial Public Offering[5:30:00 PM ET]SABA$7.62-0.03(-0.39%)SABA Announces Notification of Sources of Distributions[5:30:00 PM ET]BRW$6.00+0.01(+0.17%)BRW Announces Notification of Sources of Distributions[5:30:00 PM ET]MUEL$416.00-6.00(-1.42%)Paul Mueller Company Announces Its Third Quarter Earnings of 2026[5:28:01 PM ET]NBRKF$0.13-0.00(-2.00%)New Break Announces $550,000 Non-Brokered Private Placement Offering of Flow-Through Shares[5:23:00 PM ET]FUJIY$10.98+0.06(+0.55%)Fujifilm to Increase Production Capacity by 5x for Magnetic Data Storage Tape[5:18:00 PM ET]ATNM$1.44-0.09(-5.88%)Actinium Pharmaceuticals Announces Inducement Grant to New Employee Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a pioneer in the development of targeted radiotherapies, today...[5:15:00 PM ET]SFDL$46.50-0.35(-0.75%)Security Federal Corporation Announces Increase in Quarterly and Year-to-Date Earnings[5:07:53 PM ET]TAIT$1.92-0.03(-1.54%)Taitron Announces Quarterly Cash Dividend[5:05:00 PM ET]ORZCF$1.84-0.10(-5.15%)Orezone Files Technical Report for the Casa Berardi Updated Life-of-Mine Plan[5:00:00 PM ET]ANVS$1.17+0.15(+14.71%)Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE[5:00:00 PM ET]

CAR · NASDAQ

Avis Budget Group, Inc.

$108.10 -0.06 (-0.06%)

Company overview

Avis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary products and services to businesses and consumers. It operates the Avis brand, which offers vehicle rental and other mobility solutions to the premium commercial and leisure segments of the travel industry; the Budget Truck brand, a local and one-way truck and cargo van rental business with a fleet of approximately 20,000 vehicles rented through a network of approximately 465 dealer-operated and 385 company-operated locations serving consumer and light commercial sectors in the continental United States; and the Zipcar brand, a car sharing network. The company also operates various other car rental brands, such as Budget, Payless, Apex, Maggiore, MoriniRent, FranceCars, Amicoblue, Turiscar, and ACL Hire.

Sector
Industrials
Industry
Rental & Leasing Services
Exchange
NASDAQ
Market cap
$3.8B
Employees
17,000
Headquarters
Parsippany, NJ
CEO
Brian J. Choi
Listed
September 14, 1983
P/E
-5.71
Dividend yield
5.19%

Company financials

Revenue
$11.8B
Gross profit
$3B
Operating income
$1.3B
EBITDA
$5.3B
Net income
-$667M
EPS
-$18.93
Total assets
$30.6B
Total debt
$27.7B
Gross margin
25.59%
Net margin
-5.68%
Earnings yield
-17.51%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

92.92122.02151.12180.21209.31
CAR 1D NASDAQ O102.69H108.43L101.67C108.16+6.42 (+6.31%)Vol380.81K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
CARAvis Budget Group, Inc. Stock news Cartesian: Maintaining 'Buy' On Descartes-08 MG Data Release And CAR-T Agreement Seeking Alpha
CARAvis Budget Group, Inc. Stock news Earnings Preview: Avis Budget Group (CAR) Q3 Earnings Expected to Decline Zacks Investment Research
CARAvis Budget Group, Inc. Press release Avis First Expands to London Heathrow and Paris Charles de Gaulle Airports Business Wire
CARAvis Budget Group, Inc. Press release Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial PRNewsWire
CARAvis Budget Group, Inc. Stock news Carclo (LON:CAR) Stock Price Breaks Above Two Hundred Day Moving Average – Should You Sell? Defense World
CARAvis Budget Group, Inc. Press release Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma ACCESS Newswire
CARAvis Budget Group, Inc. Press release Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy GlobeNewswire
CARAvis Budget Group, Inc. Press release Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics GlobeNewswire
CARAvis Budget Group, Inc. Press release Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference Anixa Biosciences, Inc. PR Newswire
CARAvis Budget Group, Inc. Press release Avis Budget Group to Announce Third Quarter 2026 Results on November 03, 2026 GlobeNewswire
CARAvis Budget Group, Inc. Stock news Hertz Rebounds 16% From a Record Low; Avis Climbs 5%, Ryder Ticks Up 24/7 Wall Street
CARAvis Budget Group, Inc. Press release Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial PRNewsWire
CARAvis Budget Group, Inc. Stock news Can Higher Fleet Utilization Boost Avis Budget's Profitability? Zacks Investment Research
CARAvis Budget Group, Inc. Press release Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma GlobeNewsWire
CARAvis Budget Group, Inc. Press release Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial PRNewsWire
CARAvis Budget Group, Inc. Press release Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored' CAR T Therapy for Ovarian Cancer GlobeNewsWire
CARAvis Budget Group, Inc. Legal AVIS DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR Newsfile Corp
CARAvis Budget Group, Inc. Legal CAR FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR GlobeNewsWire
CARAvis Budget Group, Inc. Legal CAR FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR Newsfile Corp
CARAvis Budget Group, Inc. Legal CAR FINAL DEADLINE: ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR Newsfile Corp
FAQ

Questions about Avis Budget Group, Inc.

What does Avis Budget Group, Inc. do?
Avis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary products and services to businesses and consumers. It operates the Avis brand, which offers vehicle rental and other mobility solutions to the premium commercial and leisure segments of the travel industry; the Budget Truck brand, a local and one-way truck and cargo van rental business with a fleet of approximately 20,000 vehicles rented through a network of approximately 465 dealer-operated and 385 company-operated locations serving consumer and light commercial sectors in the continental United States; and the Zipcar brand, a car sharing network. The company also operates various other car rental brands, such as Budget, Payless, Apex, Maggiore, MoriniRent, FranceCars, Amicoblue, Turiscar, and ACL Hire.
What is CAR's market cap?
Avis Budget Group, Inc. (CAR) is a listed stock with a live quote. The latest market cap on this page is $3.8B.
Where is Avis Budget Group, Inc. headquartered?
Avis Budget Group, Inc. is headquartered in Parsippany, NJ.
How do I get CAR news from the API?
Call GET /v1/news?tickers=CAR. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does CAR news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for CAR, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the CAR price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.